IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Neos Therapeutics, Inc. & Advises Investors with Losses...
September 19 2016 - 2:18PM
Business Wire
Lundin Law PC (http://lundinlawpc.com/) announces that it is
investigating claims against Neos Therapeutics, Inc. (“Neos” or the
“Company”) (Nasdaq: NEOS) concerning possible violations of federal
securities laws.
To get more information about this investigation, please contact
Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via
email at brian@lundinlawpc.com.
The investigation focuses on the Company’s August 11, 2016
announcement of its financial results for the second quarter of
2016, reporting that Neos missed its earnings expectations by $0.49
per share. When this news was announced, the Neos stock price
fell.
Lundin Law PC was founded by Brian Lundin, a securities
litigator based in Los Angeles dedicated to upholding shareholders’
rights.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160919006347/en/
Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile:
888-713-1125brian@lundinlawpc.comhttp://lundinlawpc.com/
Neos Therapeutics (NASDAQ:NEOS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neos Therapeutics (NASDAQ:NEOS)
Historical Stock Chart
From Apr 2023 to Apr 2024